Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
There, you must navigate through the maze and find a circle with the symbols. Click on the symbols as mentioned in the shrine. Once done, ask your friend to click the symbols on the shrine as well.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results